Researchers injected mice with SCIs with a nanoparticle injection, composed of poly acid. The FDA has approved the biocompatible substance for re-absorbable sutures.
Here are five takeaways:
1. The mice injected with the nanoparticle could walk better compared to those who didn’t receive the injection.
2. The injection works to prevent secondary nerve damage caused by inflammation and internal scarring. The injection does not cure the initial injury.
3. The nanoparticle injection binds the inflammation-causing cells and pushes them toward the spleen.
4. Researchers note the need for further studies to test the the nanoparticle’s safety for humans.
5. Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology at Chicago-based Feinberg School of Medicine, co-founded Cour Pharmaceuticals Development Co., which is developing the nanoparticle technology.
More articles on spine:
Drs. Jordan Glaser, Jonathan Workman & more: 5 spine, neurosurgeons making headlines
Drug treatment aims to enhance bladder compliance after SCI: 4 takeaways
Study: How do undiagnosed vertebral fractures impact older men?
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
